Transplant Diagnostics Market Incredible Possibilities of Growth and Opportunities Outcomes Analysis and Forecast to 2027

Share this news:

Increase in incidence of organ failure owing to growing cases of chronic diseases, rise in ageing population, and increase in focus on R&D is expected to propel the growth of the global transplant diagnostics market.

The non-molecular assay segment is reported to demonstrate a steady growth, due to advent of technological shift in the market. Molecular assays are expected to dominate the technology segment of the transplant diagnostics market, owing to the highly reliable results provided by these assays. Coupled with this, molecular assays used for performing transplant diagnostics procedures are equipped with highly sophisticated technology such as next-generation sequencing, which is current market trend.

The serological assay technology is the most preferred, which accounted for about half of the market share globally, in 2019. The reagents & consumables segment is projected to remain dominant throughout the forecast period. North America held the leading market position in 2019, and is expected to maintain this trend.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1135

Increase in incidence of organ failure owing to growing cases of chronic diseases, rise in ageing population, and increase in focus on R&D is expected to propel the growth of the global transplant diagnostics market. Chronic diseases can lead to organ failure in patients, which could be a significant target audience for transplant diagnostics procedures. However, difficulties in human leukocyte antigen (HLA) sequencing and increasing worldwide organ shortage can hamper the market growth.

The reagents & consumables segment accounted for the maximum revenue generation in 2015, owing to the increased number of diagnostics procedures pre and post organ transplantation. The instruments & equipment segment is projected to grow at a CAGR of 9.1% and reach $76.3 million by 2022. Both the technologies, namely non molecular assay and molecular assay hold significant position in the global transplant diagnostics market. However, molecular assay technology segment is projected to grow at the highest CAGR of 12.3%, due to highly accurate results provided by the modern molecular assay technology.

With rise in number of kidney transplants, the segment is set to report a high revenue in the future, with a CAGR of 9.8%, owing to increased incidence of renal failure worldwide. Liver and heart transplants are estimated to report a strong growth rate during the forecast duration, due to increased awareness for organ donations and increase in incidence of liver and heart failure.

Inquiry for Buying: https://www.alliedmarketresearch.com/purchase-enquiry/1135

The report also provides comprehensive analysis of the key players operating in the global transplant diagnostics market such as Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., Thermo Fisher Scientific Inc., and Sigma-Aldrich including others. The report presents competitive market study by analyzing market shares and position of major players, recent strategic moves and detailed profiles of these players.

Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: 18007925285
Website: https://www.alliedmarketresearch.com/

Release ID: 89031361

CONTACT ISSUER
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
SUBSCRIBE FOR MORE